Site content: Global

Publications

Publications

Prostate Cancer

Goldkorn et al, JAMA Netw Open 2024

Circulating Tumor Cell Count and Overall Survival in Patients With Metastatic Hormone-Sensitive Prostate Cancer

Reduzzi et al, Crit Rev Oncol Hematol 2024

Unveiling the impact of circulating tumor cells: Two decades of discovery and clinical advancements in solid tumors

de Jong et al, JCO Precis Oncol 2023

Liquid Biopsies for Early Response Evaluation of Radium-223 in Metastatic Prostate Cancer

Zhang et al, Prostate Cancer Prostatic Dis 2023

Prostein expression on circulating tumor cells as a prognostic marker in metastatic castration-resistant prostate cancer

Koinis et al, Cancers 2023

Prognostic Role of Circulating Tumor Cells in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Cabazitaxel: A Prospective Biomarker Study

Derlin et al, Prostate 2023

PSMA-heterogeneity in metastatic castration-resistant prostate cancer: Circulating tumor cells, metastatic tumor burden, and response to targeted radioligand therapy

Klusa et al, Int J Cancer 2023

Dynamics of CXCR4 positive circulating tumor cells in prostate cancer patients during radiotherapy

Gu et al, Int Urol Nephrol 2023

Circulating tumor cell quantification during abiraterone plus prednisone therapy may estimate survival in metastatic castration-resistant prostate cancer patients

Swami et al, Mol Cancer Ther 2022

External Validation of Association of Baseline Circulating Tumor Cell Counts with Survival Outcomes in Men with Metastatic Castration-Sensitive Prostate Cancer

Isebia et al, Cancers 2022

Characterizing Circulating Tumor Cells and Tumor-Derived Extracellular Vesicles in Metastatic Castration-Naive and Castration-Resistant Prostate Cancer Patients

Knipper at al, Eur Urol Open Sci 2021

Possible Role of Circulating Tumour Cells for Prediction of Salvage Lymph Node Dissection Outcome in Patients with Early Prostate Cancer Recurrence

Theil et al, Life 2021

Association of Circulating Tumor Cells with Inflammatory and Biomarkers in the Blood of Patients with Metastatic Castration-Resistant Prostate Cancer

Goldkorn et al, Clin Cancer Res 2021

Baseline Circulating Tumor Cell Count as a Prognostic Marker of PSA Response and Disease Progression in Metastatic Castrate-Sensitive Prostate Cancer (SWOG S1216)

Pereira-Veiga, Clin Exp Metastasis 2021

Longitudinal CTCs gene expression analysis on metastatic castration-resistant prostate cancer patients treated with docetaxel reveals new potential prognosis markers

Zhang et al, Biomark Res 2021

Expression of immune checkpoints on circulating tumor cells in men with metastatic prostate cancer

Markou et al, Cancers 2020

PIM-1 Is Overexpressed at a High Frequency in Circulating Tumor Cells from Metastatic Castration-Resistant Prostate Cancer Patients

Cieślikowski et al, Cancers 2020

Circulating Tumor Cells as a Marker of Disseminated Disease in Patients with Newly Diagnosed High-Risk Prostate Cancer

Budna-Tukan et al, Cancers 2019

Analysis of Circulating Tumor Cells in Patients with Non-Metastatic High-Risk Prostate Cancer before and after Radiotherapy Using Three Different Enumeration Assays

de Kruijff et al, Cancers 2019

Circulating Tumor Cell Enumeration and Characterization in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Cabazitaxel

Chen et al, Cancers 2019

In Vivo Detection of Circulating Tumor Cells in High-Risk Non-Metastatic Prostate Cancer Patients Undergoing Radiotherapy

Heller et al, J Clin Oncol 2018

Circulating Tumor Cell Number as a Response Measure of Prolonged Survival for Metastatic Castration-Resistant Prostate Cancer: A Comparison With Prostate-Specific Antigen Across Five Randomized Phase III Clinical Trials

Heller et al, Clin Cancer Res 2017

The Added Value of Circulating Tumor Cell Enumeration to Standard Markers in Assessing Prognosis in a Metastatic Castration-Resistant Prostate Cancer Population

Zhang et al, Curr Oncol Rep 2016

Clinical Utility of Circulating Tumor Cells in Advanced Prostate Cancer

Jing Li et al, Crit Rev Clin Lab Sci 2015

Using circulating tumor cells to inform on prostate cancer biology and clinical utility

Scher et al, J Clin Oncol 2015

Circulating tumor cell biomarker panel as an individual-level surrogate for survival in metastatic castration-resistant prostate cancer

De Bono et al, Clin Cancer Res 2008

Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer